DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	TNFRSF10B; TNFRSF13B; LILRA1; F2; PRL; IFNB1; IFNG; IL2RA; CD3D; GP1BA; INHBA; CD3G; SAG; CCL2; NPR1; TSHR; LAMA1; GLP1R; IFNAR2; CXCR3; CCR5; COL4A3; ADGRE1; LILRB2; ADGRE3; CLEC1B; CLEC4A; TRBV24-1; TRBV6-4; TRBV19; TRBV6-6; TRBV5-1; CD80; TRBV6-1; TRBV7-1; TRBV27; TRBV6-8; TRBV17; TRBV5-5; TRBV3-1; TRBV2; TRBV13; TRBV28; TRBV6-2; TRBV11-1; TRBV25-1; TRBV7-2; TRBV4-1; TRBV11-3; TRBV7-6; TRBV29-1; TRBV10-1; TRBV7-7; TRBV14; TRBV15; TRBV5-7; TRBV30; TRBV10-2; TRBV6-7; TRBV4-2; TRBV20-1; TRBV7-4; TRBV12-5; TRBV6-5; TRBV12-4; TRBV5-6; TRBV16; TRBV23-1; TRBV5-4; TRBV9; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; PDCD1LG2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	76	268	28.3582089552239	0	0	0	0	0	0	0
down	PSMD11; PSMD12; PSMD14; PSMD10; TAL1; PSMC3; PSMB1; PSMA1; PSMA3; PSMA4; LMO1; PSMA5; PSMB6; PSMB5; PSMC2; PSMC4; YAP1; PSMD8; PSMB2; PSMD7; PSMC6; PSMB7; PSMD1; PSME2;	GO:1902036~regulation of hematopoietic stem cell differentiation	24	68	35.2941176470588	0.00012761631203639	0.0286575190308926	0.713375184283441	0.716437975772315	0.711333323290859	0.713375184283441	0.263945020472852
down	A2ML1; SPINT1; SPINK4; CST8; PTTG1; CST4; CSTA; SLPI; CSTB; ANXA2; SPINK8; PI3; SERPINB3; SERPINB1; SPINK7; WFDC2; CST6; COL28A1; SPINK9; CST9; ITIH5; WFDC5; WFDC12; CST11; CSTL1; WFDC1; SERPINB13; UCHL5; SERPINA5; SERPINI2; SERPINA6; SERPINB7; SERPINB4; HRG; SERPINA11; SERPINB2; SERPINB12; SERPINB5; SERPINB11; SERPINA9;	GO:0010951~negative regulation of endopeptidase activity	40	148	27.027027027027	0.00015068458853173	0.0325362800006601	0.842176165303869	0.845943280017162	0.77798453058935	0.842176165303869	0.299669663714682
down	FGF10; RAMP3; APOE; HMGCR; ICAM1; BMP2; MIF; PLA2G2A; PDGFRA; ADCYAP1; FGFR3; FSHR; CALCR; S100A7; ADRA1A; FLT4; KDR; CHRNA7; PLA2G5; THPO; CASR; GATA4; CX3CL1; TEK; GPNMB; P2RY6; ANGPT1; SYT14P1; TNFAIP8L3; FFAR4; NPNT; SLC30A10; CCL19; GAREM1; TRPV4; FGF20; NOX4; TREM2; CCL11; CCL1; CCL17; HMGB1P1; XCL1; CCL22; CCL20; CCL14; CCL13; ROR1; CCL18; CCL23; CCL16;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	51	209	24.4019138755981	0.00018370580136684	0.0381971988471645	1	1	0.848720802314802	0.999999999998363	0.351808557497673
down	SRPX2; CSTA; ANXA1; KRT18; ANXA2; CDH1; JUP; CRISP2; CD24; CD34; S100A11; ICAM3; CDH5; ITGA8; CX3CL1; DSG1; FOXF1; DLG1; TRIM29; CNN3; CDSN; CRNN; CTNNA3; BAIAP2; CDH10; LRRC1; CDH6; CTNND1; CDH17; DSG3; CDH12; PKP3; DSC3; DSC2; DSC1; CDH19; IGSF5; PKP1; DSP; CDHR2;	GO:0098609~cell-cell adhesion	40	152	26.3157894736842	0.00023996362911904	0.0464536487542867	1	1	0.933043435762689	0.999999999998363	0.427853131957145
down	AKR1B10; LRAT; ADH1B; APOA1; APOE; APOC3; APOA4; LPL; RBP1; RBP3; SDC1; SDC4; ADH7; AKR1C3; AKR1C1; GPIHBP1; RDH10; RDH12; RARRES2; STRA6; BCO2; BCO1;	GO:0001523~retinoid metabolic process	22	63	34.9206349206349	0.0002699653560223	0.0488898551196524	1	1	0.963126395599629	0.999999999998363	0.450291380651646
down	PSMD11; PSMD12; PSMD14; PSMD10; PSMC3; PSMB1; PSMA1; PSMA3; PSMA4; PSMA5; PSMB6; PSMB5; PSMC2; PSMC4; PSMD8; PSMB2; PSMD7; PSMC6; PSMB7; PSMD1; FBXW11; PSME2;	GO:0038061~NIK/NF-kappaB signaling	22	63	34.9206349206349	0.0002699653560223	0.0488898551196524	1	1	0.963126395599629	0.999999999998363	0.450291380651646
down	UGT1A9; UGT1A1; UGT1A3; UGT2B28; UGT1A7; UGT1A8; UGT1A10; UGT1A6;	GO:0052697~xenobiotic glucuronidation	8	9	88.8888888888889	0.00033729908262658	0.0591749078083016	1	1	0.995517134008482	0.999999999998363	0.545020042945945
up	TRAV2; IGKV3-11; IGLV4-60; IGLV3-19; IGLV9-49; TRDV2; IGKV1-9; IGKV2D-29; IGKV1D-16; IGKV3-20; IGKV1-8; IGKV1-16; TRAV14DV4; IGLV2-11; TRDV1; IGLV1-40; TRAV38-2DV8; TRAV18; IGKV1-5; TRAV40; TRAV38-1; TRDV3; TRAV9-2; TRAV19; IGKV3-15;	GO:0002377~immunoglobulin production	25	107	23.3644859813084	0.00038802158912731	0.276426580094302	1	1	1	1	1
down	PSMD11; PSMD12; PSMD14; PSMD10; HLA-G; PSMC3; PSMB1; PSMA1; PSMA3; PSMA4; PSMA5; PSMB6; PSMB5; PSMC2; PSMC4; PSMD8; PSMB2; PSMD7; PSMC6; FCGR1B; PSMB7; PSMD1; CD207; PSME2;	GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent	24	75	32	0.00042108810832453	0.0695290776509974	1	1	0.999999999998363	0.999999999998363	0.640385296587185
down	PSMD11; PSMD12; PSMD14; PSMD10; PTTG1; CDK1; CCNB1; PSMC3; PSMB1; PSMA1; PSMA3; PSMA4; PSMA5; PSMB6; PSMB5; PSMC2; PSMC4; PSMD8; PSMB2; PSMD7; UBE2E1; PSMC6; PSMB7; PSMD1; PSME2;	GO:0031145~anaphase-promoting complex-dependent catabolic process	25	81	30.8641975308642	0.00050382705730389	0.0742388277739895	1	1	0.999999999998363	0.999999999998363	0.683763618740442
down	UGT1A9; UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A6; UGT1A10;	GO:0052696~flavonoid glucuronidation	7	7	100	0.00050964141216025	0.0742388277739895	1	1	0.999999999998363	0.999999999998363	0.683763618740442
down	DEFB4A; KRT6A; LTF; HRG; S100A9; S100A7; H2BFS; DEFB1; S100A12; DEFA5; PGLYRP4; PGLYRP3; CCL13; RNASE7; CXCL9; CXCL1; DEFA6; CXCL10; CXCL11; CXCL13; REG1A;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	21	62	33.8709677419355	0.00051188416400338	0.0742388277739895	1	1	0.999999999998363	0.999999999998363	0.683763618740442
down	CLCA1; CLDN4; GABRD; CLIC3; CFTR; GABRB3; CASR; SLC1A3; SLC1A1; GABRA2; GABRB2; CLCN3; CLCNKB; CLDN17; FXYD3; CLCA4; ANO4; SLC26A9; CLIC6; ANO3; GABRQ; CLCA3P; GABRA3; GABRA4; SLC12A8; GABRG3; GABRA5; GABRE;	GO:1902476~chloride transmembrane transport	28	97	28.8659793814433	0.00058739231779425	0.0824405118024237	1	1	0.999999999998363	0.999999999998363	0.759303781741409
down	CFTR; AQP1; SCNN1A; SCNN1B; SCNN1G; AQP4; TRPV4;	GO:0050891~multicellular organismal water homeostasis	7	8	87.5	0.0008583659896364	0.109519696950426	1	1	0.999999999998363	0.999999999998363	1
up	OR2A1; OR2A42; OR5B21; OR1F1; OR2H2; OR4E1; OR2T7; OR1E1; OR3A1; OR3A4P; OR3A3; OR4D2; OR4D1; OR2B11; OR2G6; OR2T2; OR2L13; OR2C3; OR2L5; OR2AK2; OR2L3; OR5AU1; OR4E2; OR10G2; OR6J1; OR11H7; OR10AD1; OR52B6; OR2D3; OR56A4; OR52N2; OR56B2P; OR52N4; OR56B1; OR52H1; OR52I1; OR1L8; OR1J1; OR9A1P; OR9A4; OR2T34; OR2L8; OR2AJ1; OR2T10; OR2T11; OR2T3; OR10AC1; OR2L2; OR52N5; OR52P1P; OR52I2; OR1F12; OR5K1; OR5K2; OR5B12; OR5B2; OR2A7; OR1F2P; OR2B2; OR2AG1; OR10A5; OR10A2; OR10A4; OR2D2; OR51M1; OR51I1; OR1A1; OR51B4;	GO:0050911~detection of chemical stimulus involved in sensory perception of smell	68	435	15.632183908046	0.00087910972438365	0.521898139709095	1	1	1	1	1
down	PSMD11; PSMD12; PSMD14; PSMD10; CDK1; CCNB1; PSMC3; PSMB1; PSMA1; PSMA3; PSMA4; PSMA5; PSMB6; PSMB5; PSMC2; PSMC4; PSMD8; PSMB2; PSMD7; UBE2E1; PSMC6; PSMB7; PSMD1; PSME2;	GO:1901990~regulation of mitotic cell cycle phase transition	24	80	30	0.0008974473470622	0.110166272790055	1	1	0.999999999998363	0.999999999998363	1
down	FZD9; PSMD11; PSMD12; PSMD14; FGF10; PSMD10; SCEL; JUP; PSMC3; PSMB1; PSMA1; PSMA3; PSMA4; PSMA5; PSMB6; PSMB5; PSMC2; PSMC4; YAP1; PSMD8; PSMB2; PSMD7; DLX5; PSMC6; BAMBI; KANK1; RSPO1; NRARP; PSMB7; PSMD1; LGR4; RSPO3; GSKIP; DKK2; PSME2; LYPD6;	GO:0090263~positive regulation of canonical Wnt signaling pathway	36	144	25	0.00104202744802362	0.124466853046906	1	1	0.999999999998363	0.999999999998363	1
down	CXCL11; RAMP2; RAMP3; VIP; CXCL10; ADRA2A; ADCYAP1; DRD1; DRD5; LHCGR; CALCR; MC5R; GCGR; CXCL9; ADCY2; ADGRF1; GPR26; GPR78; ADGRG6; PTGER3; LGR4; RXFP1; PTGFR; PTGER1; FSHR; ADGRL4; ADGRL3; ADGRL2;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	28	103	27.1844660194175	0.0012680010468934	0.145276691372643	1	1	0.999999999998363	0.999999999998363	1
down	MT1X; MT1E; MT1B; MT1A; MT4; MT1H; MT1M; MT1DP; MT1G;	GO:0010273~detoxification of copper ion	9	16	56.25	0.0015223585009263	0.167578835768633	1	1	0.999999999998363	0.999999999998363	1
down	PSMD11; PSMD12; PSMD14; PSMD10; PSMC3; PSMB1; PSMA1; PSMA3; PSMA4; PSMA5; PSMB6; PSMB5; PSMC2; PSMC4; PSMD8; PSMB2; PSMD7; PSMC6; PSMB7; PSMD1; WWTR1; FBXL7; FBXW11; PSME2; NCCRP1; FBXO27;	GO:0031146~SCF-dependent proteasomal ubiquitin-dependent protein catabolic process	26	95	27.3684210526316	0.00170922074987012	0.184530101726363	1	1	0.999999999998363	0.999999999998363	1
down	UGT1A9; EDF1; ZMPSTE24; APOA1; HMGCR; CYP1A1; FABP1; ALAS1; NR1D1; HNF4A; ME1; HMGCS2; HMGCS1; CYP4A11; SULT2A1; TNFAIP8L3; ANGPTL8; GOLM1; ACER1; TRIB3; NPAS2; C1QTNF2; ANGPTL4; GRHL1; PSAPL1;	GO:0019216~regulation of lipid metabolic process	25	92	27.1739130434783	0.00224625802842782	0.229281683119887	1	1	0.999999999998363	0.999999999998363	1
down	GMDS; KRT19; ANXA4; BMP2; GOT1; AGXT; HOXD3; HNF1B; CDH6; FOXA1; MESP2; CNTN1; FOXC1; TBX2; NR0B2; HES5; RIPPLY2; NRARP; PERP; NR1H4; MESP1; CHAC1; GRIP2; WDR12; TMEM100; HEY2; NOTCH3; SORBS2;	GO:0007219~Notch signaling pathway	28	109	25.6880733944954	0.00254602180241359	0.248507746973602	1	1	0.999999999998363	0.999999999998363	1
down	AKR1C3; ALDH1A3; AKR1C1; RDH10; SDR16C5; RDH13; BCO2; BCO1;	GO:0042574~retinal metabolic process	8	14	57.1428571428571	0.00257785287356704	0.248507746973602	1	1	0.999999999998363	0.999999999998363	1
down	PSMD11; PSMD12; PSMD14; WNT9B; FZD7; PSMD10; PSMC3; PSMB1; PSMA1; PSMA3; PSMA4; PSMA5; PSMB6; PSMB5; PSMC2; PSMC4; PSMD8; PSMB2; PSMD7; PSMC6; ROR1; PSMB7; PSMD1; PSME2;	GO:0060071~Wnt signaling pathway, planar cell polarity pathway	24	88	27.2727272727273	0.00261167742633461	0.248507746973602	1	1	0.999999999998363	0.999999999998363	1
down	PSMD11; PSMD12; PSMD14; PSMD10; IL1A; PSMC3; IL1RN; PSMB1; PSMA1; PSMA3; PSMA4; PSMA5; PSMB6; PSMB5; PSMC2; PSMC4; PSMD8; PSMB2; PSMD7; PSMC6; PSMB7; PSMD1; IL1RL2; FBXW11; PSME2;	GO:0070498~interleukin-1-mediated signaling pathway	25	95	26.3157894736842	0.00321263237180525	0.300595302255244	1	1	0.999999999998363	0.999999999998363	1
down	CLCA1; GRID2; ATP2C2; ATP6V1G1; ATP1B1; S100A6; GJA1; ATP4A; CHRNA7; SCNN1A; GRIA1; ATP1A2; SCNN1B; SCNN1G; CLCNKB; ATP1B3; GRIK2; GRIK3; FXYD3; CLCA4; GRIK4; ANO4; PDZD11; TMC5; GJD3; ATP6V1C2; ANO3; ATP6V0A4; SGK2; ASIC5; UNC79; ATP6V1D; CLCA3P; GABRA3; GABRA5; GABRB3; GABRG3; GABRA2; GABRD; GABRQ; GABRE; GABRA4; HTR3B; HTR3A; GABRB2;	GO:0034220~ion transmembrane transport	45	208	21.6346153846154	0.00328625217176381	0.302066120063538	1	1	0.999999999998363	0.999999999998363	1
down	COL6A5; ISLR; EFS; EDIL3; CNTN5; ITGBL1; ATP1B1; ICAM1; HAPLN1; CEACAM1; MAG; ACHE; AZGP1; EPHA2; EPHA3; COL15A1; CXCL12; CCL11; EFNB2; EMP2; SLURP1; AFDN; CDH6; LGALS4; RND3; CLDN10; CX3CL1; DSC2; TYRO3; DPT; LGALS3BP; CNTN1; CDH17; PKP1; LY6D; MYBPC2; HABP2; DSC3; OPCML; CDSN; COL28A1; FLG2; HES5; GRHL2; AMTN; EGFL6; MUC16; MAGI1; AMELX; CGREF1; BOC; CDHR5; STAB1; PCDHB8; PCDH17; PCDHA13; PCDHA3; PCDH1; CDH16; PCDHA7; PCDHGA2; PCDHA10; PCDHAC2; PCDHA11; SIGLEC6; PCDH11Y; PCDHA5; PCDHB5; PCDHA9; PCDHGA1; PCDHB10; PCDHGB4; PCDHB11; SIGLEC8; PCDH18; PCDHA4; PCDH11X; ICAM3; PARD3; PCDHGC4; GPNMB; PCDHB4; PCDHA8; PCDHA12; PCDHA6;	GO:0007155~cell adhesion	85	454	18.7224669603524	0.00340637661418663	0.302066120063538	1	1	0.999999999998363	0.999999999998363	1
down	ACKR2; CD5L; ANXA1; S100A8; S100A9; KRT16; BMP2; MIF; FOLR2; DPEP1; SELE; SDC1; CRHBP; EPHA2; BDKRB2; FCGR2B; XCR1; BDKRB1; CSRP3; CARD18; ELF3; S100A12; MS4A2; HYAL1; IL18; IL17A; ECM1; IL34; TRIL; NLRP10; PLD4; IL17F; NR1H4; MGLL; CCL19; RARRES2; IL1RL2; CYP4F11; PLGRKT; NOX4; STAB1; PLAA; PTGER3; CCL11; IL36A; ACKR1; CCL1; PTGFR; CCL23; CXCL1; CXCL13; CCL16; CCL17; PTGER1; CCL14; GPR33; AGTR1; CXCL9; IL36G; IL1A; IL36RN; CCL13; CCL22; XCL1; CCL18; IL1F10; IL1RN; IL36B; CX3CL1; CXCL11; GGT5; CCL20; CXCL10;	GO:0006954~inflammatory response	73	381	19.1601049868766	0.00388013576773705	0.330046700001148	1	1	0.999999999998363	0.999999999998363	1
down	PTGES; EDN1; MIF; EDN2; PLA2G4A; PTGIS; PLA2G4F; MGST1;	GO:0001516~prostaglandin biosynthetic process	8	16	50	0.00477863475588414	0.38119305041537	1	1	0.999999999998363	0.999999999998363	1
down	EDN1; ADRA2A; EDN3; EDN2; BDKRB2; AGTR1; ATP1A2; ACE2;	GO:0019229~regulation of vasoconstriction	8	16	50	0.00477863475588414	0.38119305041537	1	1	0.999999999998363	0.999999999998363	1
down	EDN1; EDN3; EDN2; HRC; AVPR1A; SLC1A1; NMU; RGS4; HEY2;	GO:0010460~positive regulation of heart rate	9	20	45	0.00482093099029057	0.38119305041537	1	1	0.999999999998363	0.999999999998363	1
up	AGRN; FN1; PDGFA; APP; SERPINE1; THBS1; CD44; ITGB4; ITGA2; ITGB6; COL8A2; LAMA1; ITGA3; LOX; COL4A5; COL4A4; MFAP2; HSPG2; COL4A3; COL7A1; COL16A1; LAMB3; LAMC2; COL4A6; COL19A1; LAMA3; PXDN; ICAM5; NR2E1; COL27A1; COL17A1; COL22A1; MMP10; MMP8; MMP14; MMP17; MMP19; POSTN;	GO:0030198~extracellular matrix organization	38	230	16.5217391304348	0.00494031581323384	0.897781149238846	1	1	1	1	1
down	PTGES; FGF10; GJB6; CLDN1; REN; PENK; SLPI; CYP1A1; S100A8; EDN1; MGST1; SCGB1A1; IDO1; SELE; GJA1; UGT1A1; MAOB; GJB2; IL12A; S100A7; PTGER1; PCK1; PTGFR; BDKRB1; MGST2; TRIM6; S100A14; GNG12; TNFRSF11A; GGT5; NOS1; NOS2;	GO:0032496~response to lipopolysaccharide	32	138	23.1884057971014	0.00505358860422289	0.384695129331904	1	1	0.999999999998363	0.999999999998363	1
down	MPZL2; FGF1; KRT18; CPM; CASR; MNX1; EFNB2; TPD52; CST6; KRT35; MRPL40; PHLDA3; LYVE1; SOX17; FOXQ1; FOXD4L3; SOX21; FOXD4L4; FOXC1; FOXD4L5; SOX2; FOXS1; FOXA3; SRY; SOX7; FOXD4; FOXA1; FOXI2; PITX1; SOX18;	GO:0009653~anatomical structure morphogenesis	30	127	23.6220472440945	0.00519579110540824	0.384695129331904	1	1	0.999999999998363	0.999999999998363	1
down	PLA2G4A; CYP2J2; CYP4F2; PTGIS; CYP4F22; CYP2S1;	GO:0006690~icosanoid metabolic process	6	9	66.6666666666667	0.00520784286234854	0.384695129331904	1	1	0.999999999998363	0.999999999998363	1
down	APOA1; APOE; APOC3; APOA4; LPL; GPIHBP1;	GO:0034371~chylomicron remodeling	6	9	66.6666666666667	0.00520784286234854	0.384695129331904	1	1	0.999999999998363	0.999999999998363	1
down	ALOX15B; FABP5; PTGIS; LMO3; CITED2; STARD10;	GO:0035360~positive regulation of peroxisome proliferator activated receptor signaling pathway	6	9	66.6666666666667	0.00520784286234854	0.384695129331904	1	1	0.999999999998363	0.999999999998363	1
down	PSMD11; PSMD12; PSMD14; CTNND1; PSMD10; DKK1; APOE; BMP2; PSMC3; IGFBP2; PSMB1; IGFBP6; PSMA1; PSMA3; PSMA4; PSMA5; PSMB6; PSMB5; PSMC2; PSMC4; SOX2; PSMD8; PSMB2; PSMD7; PSMC6; SOSTDC1; SHISA6; KREMEN2; NKD2; PSMB7; PSMD1; WWTR1; SOX17; DKK4; DKK2; PSME2; RUVBL2; MAPK8IP2; NOTUM;	GO:0090090~negative regulation of canonical Wnt signaling pathway	39	179	21.7877094972067	0.00531401365766004	0.387439904858487	1	1	0.999999999998363	0.999999999998363	1
down	UGT1A9; UGT1A1; UGT1A7; UGT1A10; UGT1A8;	GO:0051552~flavone metabolic process	5	6	83.3333333333333	0.00569238840578967	0.39946335637629	1	1	0.999999999998363	0.999999999998363	1
down	TCF21; ID1; FOXF1; STRA6; ERRFI1;	GO:0060426~lung vasculature development	5	6	83.3333333333333	0.00569238840578967	0.39946335637629	1	1	0.999999999998363	0.999999999998363	1
down	GABRB2; GABRG3; GABRA5; GABRA4; GABRA3; GABRA2; GABRE;	GO:0051932~synaptic transmission, GABAergic	7	13	53.8461538461538	0.00606962089670837	0.412849176962865	1	1	0.999999999998363	0.999999999998363	1
down	FMO2; CYP2F1; CYP2J2; CYP2C19; CYP2W1; CYP2E1; CYP2S1; CYP2C9; CYP2C18;	GO:0006082~organic acid metabolic process	9	21	42.8571428571429	0.00617729441839698	0.412849176962865	1	1	0.999999999998363	0.999999999998363	1
down	PLA2G10; PLA2G2A; PLA2G5; PLA2G4A; PLA2G4E; PLA1A; PLA2G4F; PLA2G4D; PLA2G2F;	GO:0036150~phosphatidylserine acyl-chain remodeling	9	21	42.8571428571429	0.00617729441839698	0.412849176962865	1	1	0.999999999998363	0.999999999998363	1
down	PSMD11; PSMD12; PSMD14; NRG2; SPTBN2; FGF10; GFRA3; PSMD10; RASAL1; TGFA; FGF1; PDGFRA; PSMC3; PSMB1; FGF7; ERBB3; FGFR3; PSMA1; PSMA3; PSMA4; PSMA5; PSMB6; PSMB5; MAPK4; BTC; PSMC2; GDNF; PSMC4; PSMD8; PSMB2; PSMD7; PSMC6; TEK; DLG1; IL18; ANGPT1; MAPK6; DUSP5; EPGN; KLB; PBK; HBEGF; PSMB7; PSMD1; NRTN; DUSP9; GFRA4; FGF20; LAMTOR3; RASAL2; PSME2;	GO:0000165~MAPK cascade	51	254	20.0787401574803	0.00661454363048775	0.431791255134398	1	1	0.999999999998363	0.999999999998363	1
down	CYP1A1; CYP2C9; CYP2C19; CYP4F2; CYP4A11; CYP4A22;	GO:0097267~omega-hydroxylase P450 pathway	6	10	60	0.00750990606667656	0.466373476375909	1	1	0.999999999998363	0.999999999998363	1
down	EDN1; ICAM1; NR1D1; PCK1; LCN2; HYAL1; IL17A; PTGIS; CCL16; CCL17; CCL13; CCL14; XCL1; CCL22; CCL20; CX3CL1; CCL11; CCL18; CCL1; CCL23; CCL19;	GO:0071347~cellular response to interleukin-1	21	81	25.9259259259259	0.00751078343105682	0.466373476375909	1	1	0.999999999998363	0.999999999998363	1
up	IFNB1; IFNG; RET; LIF; IFNA21; IFNW1; IFNA5;	GO:0033141~positive regulation of peptidyl-serine phosphorylation of STAT protein	7	19	36.8421052631579	0.00754772633455236	0.897781149238846	1	1	1	1	1
down	NFIB; UPK1B; LRAT; TF; CYP2E1; LPL; BMP2; FABP4; PRLR; FCGR2B; NOS2; ADH7; DEFB1; SLC10A2; FER1L6; NAALADL2; GKN2; HERC6; MT1M; STOX2; ADAMTS9; BAIAP2; DGKB;	GO:0009617~response to bacterium	23	92	25	0.0076418608482185	0.466373476375909	1	1	0.999999999998363	0.999999999998363	1
down	PSMD11; PSMD12; TNFRSF11B; PSMD14; PSMD10; KRT18; KRT8; PSMC3; PSMB1; PSMA1; PSMA3; PSMA4; PSMA5; PSMB6; PSMB5; PSMC2; TNFSF9; PSMC4; PSMD8; PSMB2; PSMD7; PSMC6; PSMB7; PSMD1; TXNDC17; TNFRSF19; PSME2; TNFRSF11A;	GO:0033209~tumor necrosis factor-mediated signaling pathway	28	120	23.3333333333333	0.00775116019704736	0.466373476375909	1	1	0.999999999998363	0.999999999998363	1
down	KRT18; KRT16; KRT3; KRT6C; KRT74; EVPLL; PPL; DSP; EVPL;	GO:0045104~intermediate filament cytoskeleton organization	9	22	40.9090909090909	0.00780888970062976	0.466373476375909	1	1	0.999999999998363	0.999999999998363	1
down	GSTA4; GSTA1; GSTA2; GSTP1; GSTT2B; MGST1; GSTA3; MGST2; GSTO2;	GO:1901687~glutathione derivative biosynthetic process	9	22	40.9090909090909	0.00780888970062976	0.466373476375909	1	1	0.999999999998363	0.999999999998363	1
down	PTGES; GSTA1; AKR1C3; AKR1C2; PTGR1; CYP2S1; PLAA; AKR1C1;	GO:0006693~prostaglandin metabolic process	8	18	44.4444444444444	0.0081884339885423	0.473916169192541	1	1	0.999999999998363	0.999999999998363	1
down	PLA2G10; PLA2G2A; PLA2G5; PLA2G4A; PLA2G4F; PLA2G4D; PLA2G2F; PLA2G3;	GO:0036148~phosphatidylglycerol acyl-chain remodeling	8	18	44.4444444444444	0.0081884339885423	0.473916169192541	1	1	0.999999999998363	0.999999999998363	1
down	FGF10; TCF21; PDGFRA; HNF1B; FOXF1; IHH; RBPMS2; OVOL2;	GO:0048557~embryonic digestive tract morphogenesis	8	18	44.4444444444444	0.0081884339885423	0.473916169192541	1	1	0.999999999998363	0.999999999998363	1
down	PTGES; CXCL13; S100A8; GJA1; CCL11;	GO:0002544~chronic inflammatory response	5	7	71.4285714285714	0.00881862142566603	0.494482919543447	1	1	0.999999999998363	0.999999999998363	1
down	EDN1; EDN3; EDN2; EDNRB;	GO:0014826~vein smooth muscle contraction	4	4	100	0.00913170346547665	0.497722167526077	1	1	0.999999999998363	0.999999999998363	1
down	ANXA8; PLA2R1; ANXA1; ANXA8L1;	GO:1900138~negative regulation of phospholipase A2 activity	4	4	100	0.00913170346547665	0.497722167526077	1	1	0.999999999998363	0.999999999998363	1
down	CCL22; CXCL11; DEFB4A; CCL16; PIK3C2G; CXCL14; CXCL10; HRG; CXCL1; CCL1; CXCL12; CCL11; CCL23; CCL18; DEFB1; CX3CL1; CCL20; CXCL9; PLD1; ENPP2; ECSCR; CCL17; CCL13; RARRES2; PLGRKT; CXCR1; XCR1; ACKR2;	GO:0006935~chemotaxis	28	122	22.9508196721311	0.0092968702695897	0.501852208591121	1	1	0.999999999998363	0.999999999998363	1
down	APOE; ATP1B1; EDN3; DRD5; CCL1; KEL; CDH5; CHRNA7; CASR; CXCL12; CSRP3; CCL11; STC1; CCL23; ANK2; GRIK2; RGN; CCL14; CCL13; CCL19; TRPV4; STOML2; ATP2C2;	GO:0006874~cellular calcium ion homeostasis	23	94	24.468085106383	0.00941779066228798	0.503537874076998	1	1	0.999999999998363	0.999999999998363	1
down	PSMD14; CLDN7; CLDN1; PENK; HMGCR; S100A8; CYP2E1; ICAM1; CDK1; GSTP1; NQO1; ADCYAP1; NPPC; CCND1; MAOB; ADH7; ADCYAP1R1; HTR3A; RGS4; CLDN18; ACTC1; GRIN2A; SETD7; KCNC2;	GO:0045471~response to ethanol	24	100	24	0.00984334968827716	0.51645387990643	1	1	0.999999999998363	0.999999999998363	1
down	UNC13B; GIPC1; GRM6; CACNA1G; HCRTR2; GALR3; SNCG; HTR3B; DRD5; CBLN1; SLC6A2; SLC6A1; GRIA1; SLC1A3; SLC1A1; HTR3A; OMP; NPTX2; SLC1A6; HAP1; FGF12; GRIN2A; GRIK2; PMCHL1; GRIK4; SYT10; PMCHL2; LPAR3; PCDHB10; PCDHB5; PCDHB4; PCDHB11; GABRA4; GABRB3; GABRQ; GABRE; DLG1; HTR4; GABRB2; CHRNA7; CHRM2; PENK; HTR1F; GABRA2; GABRG3; GABRA3; GABRA5; HTR1D; GABRD;	GO:0007268~chemical synaptic transmission	49	249	19.6787148594378	0.0103986023942877	0.533571877136429	1	1	0.999999999998363	0.999999999998363	1
down	PLA2G10; PLA2G2A; PLA2G5; PLA2G4A; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F;	GO:0036149~phosphatidylinositol acyl-chain remodeling	8	19	42.1052631578947	0.0104547393097626	0.533571877136429	1	1	0.999999999998363	0.999999999998363	1
down	DAPL1; CFAP69; MSGN1; SRRM4; KRT6A; TFF1; INHA; FGF1; MAL; HIST1H1T; ANXA13; COL15A1; ADCYAP1R1; TPPP2; KRTDAP; BNC1; NHLH2; SIM2; ANGPT1; SHB; INA; ECSCR; ODF4; ZNF750; TMEM176B; MORN2; NKAPL; CXCL17; SPATA19; EGFL6; ATOH7; ANKS4B; ACER1; TCP11; NELL1; TBATA; ATOH8; CITED2; RARRES2; CHRDL1; NAA15; TEX15; CDHR5; NPAP1; THEG; NDRG2; SPIC; FST; SOX17; POU3F1; NKX2-8; HES5; POU2F3; FOXA1; FOXD4L3; SPINK6; FOXS1; NR1H4; FOXI2; NR1D1; ID1; HNF4A; FOXA3; SPDEF; NKX6-1; FOXC1; CDX1; FOXD4; RXRG; CCDC160; SOX18; NKX6-2; FOXQ1; FOXD4L5; HNF4G; EYA2; SRY; ELF5; PTK6; NHSL1; NKX2-3; SOX2; NR2F6; FRK; SOX7; EHF; DLX5; HES2; NKX1-2; SOX21; SPINK5; HES4; ID4; ELF3; SRMS; FOXD4L4; CAV2; DLX3; HEY2;	GO:0030154~cell differentiation	99	572	17.3076923076923	0.011618610231164	0.577229007413756	1	1	0.999999999998363	0.999999999998363	1
up	INHBA; ITGB4; ITGA2; ITGA3; HMGA2;	GO:0048333~mesodermal cell differentiation	5	11	45.4545454545455	0.01202615321922	0.897781149238846	1	1	1	1	1
down	PSMA3; PSMB5; PSMA1; PSMB7; PSMB6; PSMA4; PSMB2; PSMB1; PSMA5;	GO:0010499~proteasomal ubiquitin-independent protein catabolic process	9	24	37.5	0.0120305047868375	0.587297859767878	1	1	0.999999999998363	0.999999999998363	1
up	TYROBP; CTLA4; IL10; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	6	16	37.5	0.0122990313199938	0.897781149238846	1	1	1	1	1
up	SIX1; PROX1; SIX4;	GO:0030910~olfactory placode formation	3	3	100	0.0125261467124427	0.897781149238846	1	1	1	1	1
up	VIL1; CD44; PDPN;	GO:2000392~regulation of lamellipodium morphogenesis	3	3	100	0.0125261467124427	0.897781149238846	1	1	1	1	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0125261467124427	0.897781149238846	1	1	1	1	1
down	GJB6; GJB1; GJA1; GJB2; GJD3;	GO:0016264~gap junction assembly	5	8	62.5	0.0129551586837364	0.620547136926141	1	1	0.999999999998363	0.999999999998363	1
down	DKK1; C1QA; C1QB; C1QC; CX3CL1;	GO:0098883~synapse pruning	5	8	62.5	0.0129551586837364	0.620547136926141	1	1	0.999999999998363	0.999999999998363	1
down	RAMP2; RAMP3; ATP2C2; NFASC; TSPAN15; ATP1B1; ANXA2; RAP2A; CDH1; JUP; EPHA2; DPP6; ATP1B3; EMP2; S100A10; ANK2; DLG1; MAP7; TMED2; WDR72; ABCA12; DPP10; MRAP; KCNB2; NKD2; MRAP2; CRB3; FAM126A; PKP3; RAB40AL; RAB3C;	GO:0072659~protein localization to plasma membrane	31	144	21.5277777777778	0.0136038684567383	0.638251103920141	1	1	0.999999999998363	0.999999999998363	1
down	PLA2G10; APOA4; LIPF; PLA2G2A; SULT2A1; PLD1; PLCH1; LIPK; LIPM; PLCXD3; LIPI; ASPG; PLCZ1; LIPH; PLA2G2F; PLA2G3; PLA1A; LPL; PNLIPRP3; CES3;	GO:0016042~lipid catabolic process	20	81	24.6913580246914	0.0136427026131843	0.638251103920141	1	1	0.999999999998363	0.999999999998363	1
up	GATA2; PAX6; SATB2; TBR1;	GO:0021902~commitment of neuronal cell to specific neuron type in forebrain	4	7	57.1428571428571	0.0138447318254087	0.897781149238846	1	1	1	1	1
down	EDN1; EDN3; EDN2; KEL; EDNRB; HTR1D; BDKRB2;	GO:0042310~vasoconstriction	7	16	43.75	0.0139866559200768	0.640849378108341	1	1	0.999999999998363	0.999999999998363	1
down	SULT1C4; SULT1A3; ADH7; ALDH3B2; SULT1E1; SULT2A1;	GO:0006068~ethanol catabolic process	6	12	50	0.0141548491067749	0.640849378108341	1	1	0.999999999998363	0.999999999998363	1
down	APOA1; APOE; APOC1; APOC3; APOA4; ABCA12;	GO:0033700~phospholipid efflux	6	12	50	0.0141548491067749	0.640849378108341	1	1	0.999999999998363	0.999999999998363	1
down	RAMP2; CEACAM1; CD34; KDR; TMEM100; ASB4;	GO:2001214~positive regulation of vasculogenesis	6	12	50	0.0141548491067749	0.640849378108341	1	1	0.999999999998363	0.999999999998363	1
down	MT1A; MT1E; MT1B; MT1G; MT1H; MT1X; MT1M; MT1DP; MT4;	GO:0071294~cellular response to zinc ion	9	25	36	0.0146873563121446	0.649073611768273	1	1	0.999999999998363	0.999999999998363	1
down	APOE; EDN1; MIF; EDNRB;	GO:0032269~negative regulation of cellular protein metabolic process	4	5	80	0.0149145878015866	0.649073611768273	1	1	0.999999999998363	0.999999999998363	1
down	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.0149145878015866	0.649073611768273	1	1	0.999999999998363	0.999999999998363	1
down	GJB5; GJB1; GJA1; GJB2;	GO:1905867~epididymis development	4	5	80	0.0149145878015866	0.649073611768273	1	1	0.999999999998363	0.999999999998363	1
up	ITGB4; LAMB3; LAMC2; LAMA3; COL17A1;	GO:0031581~hemidesmosome assembly	5	12	41.6666666666667	0.0157703445710768	0.897781149238846	1	1	1	1	1
down	PSMD11; PSMD12; PSMD14; PSMD10; HSPB1; SCGB1A1; PSMC3; PSMB1; PSMA1; PSMA3; PSMA4; PSMA5; PSMB6; PSMB5; PSMC2; PSMC4; PSMD8; PSMB2; PSMD7; PSMC6; PSMB7; PSMD1; EXOSC4; PSME2; CARHSP1;	GO:0043488~regulation of mRNA stability	25	112	22.3214285714286	0.017550396608824	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	PLA2G10; PLA2G2A; PLA2G5; PLA2G4A; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F; PLA2G3;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	9	26	34.6153846153846	0.0177521925275285	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	CA2; KRT6A; KRT16; SERPINB5; CA9; FRAS1; TBX5;	GO:0002009~morphogenesis of an epithelium	7	17	41.1764705882353	0.0177781940465155	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	ALOX15B; PLA2G10; LPL; PLA2G2A; AGTR1; PLA2G5; IL18;	GO:0010744~positive regulation of macrophage derived foam cell differentiation	7	17	41.1764705882353	0.0177781940465155	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	SLC1A7; SYNGR3; SLC1A3; SLC1A6; ATP1A2;	GO:0001504~neurotransmitter uptake	5	9	55.5555555555556	0.0182257734451143	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	APOA1; APOE; APOC1; APOA4; AGTR1;	GO:0010873~positive regulation of cholesterol esterification	5	9	55.5555555555556	0.0182257734451143	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	SULT1C2; SULT1C4; SULT1A3; SULT1E1; SULT2A1;	GO:0051923~sulfation	5	9	55.5555555555556	0.0182257734451143	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	DNPH1; PNP; XDH; NT5C1A; NUDT15; GDA;	GO:0006195~purine nucleotide catabolic process	6	13	46.1538461538462	0.01866325699995	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	CLDN5; RAMP2; DDAH1; SLIT2; CEACAM1; ANGPT1;	GO:0043116~negative regulation of vascular permeability	6	13	46.1538461538462	0.01866325699995	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
up	TLR9; TLR8; TLR7;	GO:0045356~positive regulation of interferon-alpha biosynthetic process	3	4	75	0.0204337205462184	0.897781149238846	1	1	1	1	1
down	ALOX15B; PLA2G10; ALOX12B; PLA2G4A; CYP4F2; CYP4A11; MGLL; ALOXE3; CYP4F11;	GO:0019369~arachidonic acid metabolic process	9	27	33.3333333333333	0.0212568463217884	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	FGF10; RAMP2; ASS1; PENK; CRYAB; GSTP1; NQO1; GJA1; IGFBP2; BMP7; PTN; CCND1; GJB2; SLC6A1; ADCYAP1R1; PTGFR; FOXA1; IHH; RBBP8; ARNT2; WFDC1; ANXA1; GGT5;	GO:0032355~response to estradiol	23	103	22.3300970873786	0.0219431929509133	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	ALOX12B; GSTA1; GSTP1; CYP2J2; ELOVL1; ALOXE3; ALOX15B;	GO:0043651~linoleic acid metabolic process	7	18	38.8888888888889	0.0222376583775845	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	DSP; DES; KRT9; KRT20; KRT2; KRT17; TCHH;	GO:0045109~intermediate filament organization	7	18	38.8888888888889	0.0222376583775845	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	BMP7; BMP5; CSRP3; TBX2; SGCG; GATA4; SGCD;	GO:0048738~cardiac muscle tissue development	7	18	38.8888888888889	0.0222376583775845	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	LGI1; SLC1A3; GRIK2; NMU; CLSTN2; RIMS2; RIMS4;	GO:0050806~positive regulation of synaptic transmission	7	18	38.8888888888889	0.0222376583775845	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	CXCL10; CCL1; S100A7; CXCL12; CXCL17; LGMN; S100A14;	GO:0090026~positive regulation of monocyte chemotaxis	7	18	38.8888888888889	0.0222376583775845	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	YAP1; WWTR1; PPCS; NOX4;	GO:0003015~heart process	4	6	66.6666666666667	0.0225662443741586	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	JUP; DSP; DSC2; CTNNA3;	GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication	4	6	66.6666666666667	0.0225662443741586	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	GJB6; GJB2; MIP; GJB4;	GO:1990349~gap junction-mediated intercellular transport	4	6	66.6666666666667	0.0225662443741586	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	MAG; ASPA; ID4; HES5; NKX6-2; MYRF;	GO:0022010~central nervous system myelination	6	14	42.8571428571429	0.0240605296156071	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	IGF1; GSTP1; CX3CL1; FFAR4; TREM2; ERRFI1;	GO:0032691~negative regulation of interleukin-1 beta production	6	14	42.8571428571429	0.0240605296156071	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	SCNN1A; SCNN1B; SCNN1G; CYP4F2; CYP4A11; TFAP2B;	GO:0055078~sodium ion homeostasis	6	14	42.8571428571429	0.0240605296156071	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	FABP12; APOC3; LPL; FABP1; FABP2; FABP4; FABP5; MGLL;	GO:0019433~triglyceride catabolic process	8	23	34.7826086956522	0.0242662034662736	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	COX7A2P2; ATP2C2; ATP6V1G1; SLC2A10; CYB5A; COX6C; COX6A1; COX7A2; COX5A; COX7A1; COX7B; CLCN3; SLC9A4; OTOP3; OTOP2; SLC4A11; ATP6V1C2; COX4I2; ATP6V0A4; NDUFA4L2; ASIC5; SLC9A2; ATP6V1D; ATP1A2; ATP4A;	GO:1902600~proton transmembrane transport	25	116	21.551724137931	0.0243937773925942	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	SLC1A3; SLC1A1; CXADR; GPLD1; ABCG2;	GO:0070633~transepithelial transport	5	10	50	0.0247347387365215	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	PSCA; PATE4; LYNX1; SLURP1; LYPD6;	GO:0099601~regulation of neurotransmitter receptor activity	5	10	50	0.0247347387365215	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	PGC; KLK7; KLK5;	GO:0002803~positive regulation of antibacterial peptide production	3	3	100	0.0248918753402907	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	SLC1A7; SLC13A2; SLC25A10;	GO:0006835~dicarboxylic acid transport	3	3	100	0.0248918753402907	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	FOXH1; BMP2; GATA4;	GO:0035054~embryonic heart tube anterior/posterior pattern specification	3	3	100	0.0248918753402907	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	CBR3; CYP4F2; CYP4F11;	GO:0042376~phylloquinone catabolic process	3	3	100	0.0248918753402907	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	EDN1; BMP2; CD34;	GO:0042482~positive regulation of odontogenesis	3	3	100	0.0248918753402907	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	AGXT; GPT; GPT2;	GO:0042853~L-alanine catabolic process	3	3	100	0.0248918753402907	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	TGM1; TGM3; HRNR;	GO:0043163~cell envelope organization	3	3	100	0.0248918753402907	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	FGF10; FGF7; TMEM38B;	GO:0061033~secretion by lung epithelial cell involved in lung growth	3	3	100	0.0248918753402907	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	FGF10; GLI2; FST; FGF7; KRT17; TGM3; SOSTDC1; TMEM79; FOXQ1;	GO:0031069~hair follicle morphogenesis	9	28	32.1428571428571	0.0252317107368657	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
up	IL27; IL21; TLR9; TLR8; TLR7;	GO:0045078~positive regulation of interferon-gamma biosynthetic process	5	14	35.7142857142857	0.0254093008644982	0.897781149238846	1	1	1	1	1
up	CFAP100; HYDIN; CFAP206; DNAAF1; WDR66; DNAH5; CCDC114; DNAI2; WDR78;	GO:0003341~cilium movement	9	38	23.6842105263158	0.0255489647948077	0.897781149238846	1	1	1	1	1
up	IGHD; ORM1; ORM2; PANX3;	GO:0050716~positive regulation of interleukin-1 secretion	4	9	44.4444444444444	0.0258586389151871	0.897781149238846	1	1	1	1	1
up	TYROBP; IFNG; APP; EGR1;	GO:0050725~positive regulation of interleukin-1 beta biosynthetic process	4	9	44.4444444444444	0.0258586389151871	0.897781149238846	1	1	1	1	1
down	KPNA7; PSMC3; PSMC4; ELF3; HORMAD1; SPIC; EMG1;	GO:0001824~blastocyst development	7	19	36.8421052631579	0.0274136884156111	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	LTF; APOA4; NOS2; H2BFS; DEFB1; DEFA5; DEFA6;	GO:0002227~innate immune response in mucosa	7	19	36.8421052631579	0.0274136884156111	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	APOC1; APOC3; APOL4; APOL5; NPC1L1; APOA4; APOA1;	GO:0042157~lipoprotein metabolic process	7	19	36.8421052631579	0.0274136884156111	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
up	SNAI2; PTH; RARB; PTHLH; NKX3-2; ADAMTS7;	GO:0032331~negative regulation of chondrocyte differentiation	6	20	30	0.0276752552676879	0.897781149238846	1	1	1	1	1
up	CCL24; FGF18; TSHB; GHRH; PDGFA; WNT1; INHBA; PTHLH; TSHR; TRH; SSTR3; FASLG; CCR5; IL2; CCL7; CRB1; TNFAIP6; EFNB1; GRAP; FAT1; LILRB2; FCRL2; IL26; SIRPG; TRHDE; CCL26; PANX3; DRD2; PTH; ADRA1D; OR56A4; FGFBP2; FJX1; DRD3;	GO:0007267~cell-cell signaling	34	230	14.7826086956522	0.0284391191087896	0.897781149238846	1	1	1	1	1
up	CALCA; GPR18; OR56A4; DRD2; GPR65; P2RY10; DRD3; GPR174; GPR55;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	9	39	23.0769230769231	0.0289632181422873	0.897781149238846	1	1	1	1	1
down	EFNA1; BMP5; FOXA1; PPP2CA; VASN; TBX5; OVOL2; STRAP;	GO:0010719~negative regulation of epithelial to mesenchymal transition	8	24	33.3333333333333	0.0291053355714959	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	CLDN4; CLDN1; ANXA1; ADRA2A; KANK1; OCLN; HBEGF; DUOX2;	GO:0090303~positive regulation of wound healing	8	24	33.3333333333333	0.0291053355714959	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	IL12A; IL12B; XCL1; CD1B; CD1C; AZGP1; CD1E; HLA-G; CD1A;	GO:0001916~positive regulation of T cell mediated cytotoxicity	9	29	31.0344827586207	0.0297053187484999	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	SRRM4; FZD9; NRG2; DCLK1; MSI1; KALRN; LGI1; GJB1; CHRM2; CXCL1; NTF3; PTN; ACHE; CBLN1; EDNRB; CNTFR; GDNF; EFNA5; DLX5; FGF12; PCDH1; SIM2; CNTN4; PLPPR1; ST8SIA2; NELL1; FGF14; ATOH8; LINC01587; NRTN; CHRDL1; SDCBP2; NRN1; RAPGEFL1; PCDHA7; PCDHA6; PCDHA4; GDA; UTP11; PCDHB4; PCDHB11; PCDHA8; PCDHA5; PCDHA3; PCDHA11; PCDHA10; PCDHAC2; ERBB3; GFRA3; RBFOX1; TYRO3; ROR1; GFRA4;	GO:0007399~nervous system development	53	294	18.0272108843537	0.0299648131821733	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	GGCT; GGT5; GGT6; CHAC2; MGST2; CHAC1;	GO:0006750~glutathione biosynthetic process	6	15	40	0.0304085430131472	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	GABRA2; ICA1; SLC6A19; SLC6A15; SLC6A14; GABRQ;	GO:0006836~neurotransmitter transport	6	15	40	0.0304085430131472	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	MUC2; MUC13; STRAP; TFF3; TFF2; TFF1;	GO:0030277~maintenance of gastrointestinal epithelium	6	15	40	0.0304085430131472	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	COBL; EPS8L1; P2RY12; EPS8L2; EPS8L3; EPS8;	GO:1900029~positive regulation of ruffle assembly	6	15	40	0.0304085430131472	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
up	PTH; SSTR3; METTL21C;	GO:0008628~hormone-mediated apoptotic signaling pathway	3	5	60	0.0304876967815997	0.897781149238846	1	1	1	1	1
up	LOX; LOXL2; LOXL4;	GO:0018057~peptidyl-lysine oxidation	3	5	60	0.0304876967815997	0.897781149238846	1	1	1	1	1
up	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.0304876967815997	0.897781149238846	1	1	1	1	1
up	HMGB3; INHBA; SFRP1;	GO:0045578~negative regulation of B cell differentiation	3	5	60	0.0304876967815997	0.897781149238846	1	1	1	1	1
down	CLDN1; ASS1; EDN1; ICAM1; FABP4; NR1D1; GPD1; CRHBP; PCK1; LCN2; HYAL1; OCLN; NPNT; CCL1; CCL23; CCL22; CX3CL1; CCL17; CCL14; CCL19; CCL13; CCL18; CCL16; CCL11; CCL20; XCL1;	GO:0071356~cellular response to tumor necrosis factor	26	125	20.8	0.0307456746819758	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
up	DBH; DRD2; OPRM1; DRD3; OR56A4;	GO:0048149~behavioral response to ethanol	5	15	33.3333333333333	0.0313822853358099	0.897781149238846	1	1	1	1	1
down	SLC22A3; POMC; SCTR; HTR4;	GO:0032098~regulation of appetite	4	7	57.1428571428571	0.0322084477846408	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	PLS1; CDHR2; CDHR5; USH1C;	GO:0032532~regulation of microvillus length	4	7	57.1428571428571	0.0322084477846408	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	IDO1; NOS1; ADCYAP1R1; LRP11;	GO:0033555~multicellular organismal response to stress	4	7	57.1428571428571	0.0322084477846408	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	S100A8; SERPINB3; CX3CL1; HILPDA;	GO:0035425~autocrine signaling	4	7	57.1428571428571	0.0322084477846408	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	CD1C; CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	4	7	57.1428571428571	0.0322084477846408	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	FGF10; WNT7B; FOXJ1; ERRFI1;	GO:0060428~lung epithelium development	4	7	57.1428571428571	0.0322084477846408	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	YAP1; FOXA1; GRHL2; TMEM38B;	GO:0060487~lung epithelial cell differentiation	4	7	57.1428571428571	0.0322084477846408	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	IL33; CX3CL1; IL34; TREM2;	GO:0061518~microglial cell proliferation	4	7	57.1428571428571	0.0322084477846408	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	AQP1; RHCG; RHBG; RHCE;	GO:0072488~ammonium transmembrane transport	4	7	57.1428571428571	0.0322084477846408	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	ANXA8; SPINK6; SPINK5; ANXA8L1;	GO:1900004~negative regulation of serine-type endopeptidase activity	4	7	57.1428571428571	0.0322084477846408	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	PENK; CCK; GJA1; NPAS2;	GO:2000987~positive regulation of behavioral fear response	4	7	57.1428571428571	0.0322084477846408	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	CXCL13; EDN1; NMB; SAA1; PDGFRA; GJA1; ADCYAP1; EDN2; CCL1; EDNRB; CD24; BDKRB2; AGTR1; CCKBR; ADRA1A; AVPR1A; BDKRB1; NMU; FFAR4; PLCZ1; TRPV4; LPAR3; PTGER3; GPR33; PTGER1; XCR1; PTGFR; CALCR; CXCR1; ACKR2;	GO:0007204~positive regulation of cytosolic calcium ion concentration	30	150	20	0.0322375181871861	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	FUT1; FUT3; FUT2; FUT9; FUT6;	GO:0036065~fucosylation	5	11	45.4545454545455	0.032564208131884	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	APOE; ACHE; NSG1; DLG1; KLK6;	GO:0042982~amyloid precursor protein metabolic process	5	11	45.4545454545455	0.032564208131884	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	IRF6; KLK8; FST; KRT2; SDR16C5;	GO:0043616~keratinocyte proliferation	5	11	45.4545454545455	0.032564208131884	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	JUP; DSP; DSC2; DLG1; CTNNA3;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	5	11	45.4545454545455	0.032564208131884	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
up	COL6A6; SUSD5; NUAK1; FN1; APP; GP1BA; THBS1; CCL2; CD44; ITGB4; ITGA2; ITGB6; KITLG; CDH3; LAMA1; L1CAM; THBS2; GP5; MCAM; CXCR3; APLP1; EPHB4; CDH11; IL2; SRPX; TNFAIP6; EFNB1; COL4A3; COL7A1; COL16A1; SPOCK1; SLAMF1; LAMC2; COL4A6; ADGRE1; FAT1; MYBPC3; COL19A1; POSTN; PTPRK; KIRREL2; FEZ1; NTM; SIRPG; CD300A; CLEC4A; CTNND2; LOXL2; NINJ2; SIGLEC5; PCDHAC1; PCDHB13; PCDHB2; SIGLEC14; PCDHGC5; PCDHGB2; SPON1; ICAM5; SIGLECL1; NINJ1;	GO:0007155~cell adhesion	60	454	13.215859030837	0.0331371110750277	0.897781149238846	1	1	1	1	1
down	CCL11; CCL13; CCL1; CX3CL1; CCL18; CCL23; XCL1;	GO:0048245~eosinophil chemotaxis	7	20	35	0.0333493206025838	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	IL20RB; IL1A; IL36A; IL1RN; IL36RN; IL1F10; IL36G; IL36B;	GO:0002437~inflammatory response to antigenic stimulus	8	25	32	0.0345692814226616	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	PAH; GOT1; GPT; PYCR1; ASPA; ASPG; GPT2; FOLH1B;	GO:0008652~cellular amino acid biosynthetic process	8	25	32	0.0345692814226616	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
up	CD3D; KIT; EGR1; IL2; SOX4; RUNX2; TBX21; CD3G;	GO:0030217~T cell differentiation	8	34	23.5294117647059	0.0352264600595945	0.897781149238846	1	1	1	1	1
down	CLDN5; CHP2; CLDN7; GLP2R; VIP; KRT6A; CXCL10; S100B; IGF1; SLC25A5; FGF1; EDN1; CCK; ADRA2A; NMB; EDN3; FOLR2; PDGFRA; EPCAM; XBP1; ADCYAP1; NTF3; EDN2; PTN; FGF7; BMP5; FGFR3; EDNRB; CNTFR; SERPINB3; ALDH3A1; CCKBR; TTK; FLT4; KDR; CHRNA7; AVPR1A; GDNF; CEACAM6; MYCNOS; THPO; CASR; AKR1C3; MATK; PTGFR; ID4; EFNB2; AKR1C2; EMP2; RAB25; CX3CL1; HMGN5; BNC1; MST1R; DLG1; BAMBI; TBX2; KLF5; CCL14; HES5; EPGN; IL34; NCCRP1; KLB; DYNAP; BRK1; TFAP2B; TSLP; LGMN; WWTR1; GAREM1; ARNT2; FGF20; MCTS1; HILPDA; TNFRSF11A; REG1A; ERBB3; HBEGF; TGFA; BTC; PROK1;	GO:0008284~positive regulation of cell population proliferation	82	490	16.734693877551	0.0364700139224258	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	RAB25; IHH; DACT2; GRHL2; POF1B; PALLD;	GO:0003382~epithelial cell morphogenesis	6	16	37.5	0.0377580980289592	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	GRID2; SSTR1; GRIN2A; GRIK2; GRIK3; GRIK4;	GO:0007215~glutamate receptor signaling pathway	6	16	37.5	0.0377580980289592	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	CYP2E1; MGST1; CCND1; PSMB2; FUNDC1; MGST2;	GO:0010243~response to organonitrogen compound	6	16	37.5	0.0377580980289592	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	CYB5R2; CYB5R1; EBP; CH25H; HMGCR; MSMO1;	GO:0016126~sterol biosynthetic process	6	16	37.5	0.0377580980289592	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	SYT7; DOC2B; RIMS2; SYT8; SYT10; RIMS4;	GO:0048791~calcium ion-regulated exocytosis of neurotransmitter	6	16	37.5	0.0377580980289592	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
up	RP1; CRB1; RHO; OPN1SW; GPR88;	GO:0071482~cellular response to light stimulus	5	16	31.25	0.0381629729853615	0.897781149238846	1	1	1	1	1
up	LILRA5; IFNG; ORM1; ORM2; MMP8; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	6	22	27.2727272727273	0.0387192093499783	0.897781149238846	1	1	1	1	1
down	RBP1; ALDH1A3; RDH10;	GO:0002138~retinoic acid biosynthetic process	3	4	75	0.0397850231914048	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	C2CD4B; C2CD4A; CTNNBIP1;	GO:0002528~regulation of vascular permeability involved in acute inflammatory response	3	4	75	0.0397850231914048	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	FGF10; WNT7B; FRAS1;	GO:0003338~metanephros morphogenesis	3	4	75	0.0397850231914048	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	CYP2E1; EDN1; SCGB1A1;	GO:0010193~response to ozone	3	4	75	0.0397850231914048	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	SPDEF; SOSTDC1; NKX6-2;	GO:0010454~negative regulation of cell fate commitment	3	4	75	0.0397850231914048	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	CA2; AQP1; AQP5;	GO:0015670~carbon dioxide transport	3	4	75	0.0397850231914048	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	S100A8; NOS1; NOS2;	GO:0018119~peptidyl-cysteine S-nitrosylation	3	4	75	0.0397850231914048	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	S100A8; S100A9; SLC30A8;	GO:0032119~sequestering of zinc ion	3	4	75	0.0397850231914048	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	ADRA2A; ADRA2B; ADRA2C;	GO:0032811~negative regulation of epinephrine secretion	3	4	75	0.0397850231914048	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	CIDEA; APOA4; LY6D;	GO:0035634~response to stilbenoid	3	4	75	0.0397850231914048	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	IL12A; IL12B; IL18;	GO:0035744~T-helper 1 cell cytokine production	3	4	75	0.0397850231914048	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	SPINT1; NKX6-1; NKX6-2;	GO:0045687~positive regulation of glial cell differentiation	3	4	75	0.0397850231914048	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	FKBP4; DMRT3; DMRT1;	GO:0046661~male sex differentiation	3	4	75	0.0397850231914048	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	SOX18; OVOL2; SOX17;	GO:0060214~endocardium formation	3	4	75	0.0397850231914048	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	AKR1C3; AKR1C2; AKR1C1;	GO:0071395~cellular response to jasmonic acid stimulus	3	4	75	0.0397850231914048	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	PTN; CHRNA7; ZNF365;	GO:0140059~dendrite arborization	3	4	75	0.0397850231914048	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	MCIDAS; CCNO; DEUP1;	GO:1903251~multi-ciliated epithelial cell differentiation	3	4	75	0.0397850231914048	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	TJP1; ANGPT1; OCLN;	GO:1905605~positive regulation of maintenance of permeability of blood-brain barrier	3	4	75	0.0397850231914048	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	ADRA2A; ADRA1A; DRD1; ADRA2C; ADRA2B; DRD5; ADRB3;	GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway	7	21	33.3333333333333	0.0400812173568675	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	IGHA2; LTF; SLPI; CTSG; H2BFS; DEFB1; RNASE7; DEFA6; DEFA5;	GO:0019731~antibacterial humoral response	9	31	29.0322580645161	0.0402512876142891	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	ALOX12B; CYP4F22; FA2H; CERS3; SPTSSB; ELOVL1; ALOXE3; CERS4; DEGS2;	GO:0046513~ceramide biosynthetic process	9	31	29.0322580645161	0.0402512876142891	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	CLCA1; KCNK2; S100B; EDN1; ICAM1; FABP1; CCNB1; BMP7; PTN; AK4; AQP1; PCK1; CASR; STC1; NPEPPS; PTGIS; VASN; CPEB2; AQP3; FAM162A; ERO1A; COX4I2; HILPDA;	GO:0071456~cellular response to hypoxia	23	111	20.7207207207207	0.0414910442216705	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	REN; CTSG; CPA3; CMA1; ACE2;	GO:0002003~angiotensin maturation	5	12	41.6666666666667	0.0417727745292947	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	AK4; UQCC2; COX7A1; COX7A2; COX7A2P2;	GO:0002082~regulation of oxidative phosphorylation	5	12	41.6666666666667	0.0417727745292947	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	EDN1; EDNRB; CLCN3; ATP6V0A4; RHCG;	GO:0006885~regulation of pH	5	12	41.6666666666667	0.0417727745292947	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	ADRA2A; ATP1A2; CNN1; KCNB2; CHRM2;	GO:0006940~regulation of smooth muscle contraction	5	12	41.6666666666667	0.0417727745292947	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	GPIHBP1; MFSD2A; MAL2; RAB17; USO1;	GO:0045056~transcytosis	5	12	41.6666666666667	0.0417727745292947	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	ADRA1A; CACNA2D1; TRPM1; JPH2; JPH1;	GO:0060402~calcium ion transport into cytosol	5	12	41.6666666666667	0.0417727745292947	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
up	RHO; SAG; GNAT1; GRK1;	GO:0016056~rhodopsin mediated signaling pathway	4	11	36.3636363636364	0.042606414497623	0.897781149238846	1	1	1	1	1
up	COL4A5; COL4A3; COL4A6; COL4A4;	GO:0038063~collagen-activated tyrosine kinase receptor signaling pathway	4	11	36.3636363636364	0.042606414497623	0.897781149238846	1	1	1	1	1
up	VIL1; LMOD3; LMOD2; SCIN;	GO:0045010~actin nucleation	4	11	36.3636363636364	0.042606414497623	0.897781149238846	1	1	1	1	1
up	APOA2; IL10; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	3	6	50	0.0426619546356749	0.897781149238846	1	1	1	1	1
up	SERPINE1; SERPINE2; THBS1;	GO:0010757~negative regulation of plasminogen activation	3	6	50	0.0426619546356749	0.897781149238846	1	1	1	1	1
up	PF4; SPI1; IL10;	GO:0045347~negative regulation of MHC class II biosynthetic process	3	6	50	0.0426619546356749	0.897781149238846	1	1	1	1	1
up	SERPINE1; FAM20C; HTRA1;	GO:0097187~dentinogenesis	3	6	50	0.0426619546356749	0.897781149238846	1	1	1	1	1
up	IFNG; CCL2; CCR2;	GO:1904783~positive regulation of NMDA glutamate receptor activity	3	6	50	0.0426619546356749	0.897781149238846	1	1	1	1	1
down	POLR3G; CYP1A1; IGF1; CDK1; PAX1; IL12A; IL12B; THPO; YAP1; EMP2; DLX5; OCA2; PRDX1; FOXC1; IL18; KANK1; FAM83B; GRHL2; DUX4L9; FAM83A; OGFOD1; CITED2; GNL3; SDCBP2; FAM83D; PAK1IP1; PAK5; TACC2;	GO:0008283~cell population proliferation	28	142	19.7183098591549	0.0427243627160624	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
up	F2; PRL; IL5; KIT; IL10; IFNL1; IL26;	GO:0046427~positive regulation of receptor signaling pathway via JAK-STAT	7	29	24.1379310344828	0.0428831894029542	0.897781149238846	1	1	1	1	1
down	SULT1C2; INMT; CYP1A1; AOC1;	GO:0009308~amine metabolic process	4	8	50	0.0439033609641422	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	CEACAM1; PTN; EMP2; RHOJ;	GO:0010594~regulation of endothelial cell migration	4	8	50	0.0439033609641422	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	ADRA2A; ADRA2B; ADRA2C; P2RY12;	GO:0010700~negative regulation of norepinephrine secretion	4	8	50	0.0439033609641422	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	LTF; RNASE7; DEFA5; DEFA6;	GO:0051673~membrane disruption in other organism	4	8	50	0.0439033609641422	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	PSMD11; PSMD12; PSMD14; PSMD10; HLA-DQA2; HLA-DQB2; PSMC3; PSMB1; PSMA1; PSMA3; PSMA4; PSMA5; PSMB6; PSMB5; PSMC2; PSMC4; PSMD8; PSMB2; EIF2B2; PSMD7; PSMC6; PSMB7; PSMD1; EIF2B3; STOML2; FBXW11; PSME2; BTNL2; VTCN1; BTNL9; ICOSLG; TEC; BTNL8;	GO:0050852~T cell receptor signaling pathway	33	174	18.9655172413793	0.0447602771873994	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
up	NTRK1; CCL2; CCR2; NLGN2; SHANK3; NRXN1;	GO:0051968~positive regulation of synaptic transmission, glutamatergic	6	23	26.0869565217391	0.0451552443485995	0.897781149238846	1	1	1	1	1
down	GRXCR2; SRRM4; CNTN5; GJB6; ICAM1; GABRB3; GJB2; GABRA5; SLC1A3; GABRB2; ROR1; CRYM; CEACAM16; USH1G; MYH14; MARVELD2; MYO3A; SLITRK6; EPS8L2; ATP6V0A4; SLC52A3; HOMER2; MYO1A; DCDC2; MYO6; TIMM8B; TIMM13; USH1C;	GO:0007605~sensory perception of sound	28	143	19.5804195804196	0.0455389173968563	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
up	F2; F9; F11; GP1BA; GP5;	GO:0007597~blood coagulation, intrinsic pathway	5	17	29.4117647058824	0.0457700146516371	0.897781149238846	1	1	1	1	1
down	DDC; GGT5; PTS; KYAT3; PHGDH; HGD;	GO:0006520~cellular amino acid metabolic process	6	17	35.2941176470588	0.0461480187732559	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	CTSV; KRT36; AQP3; GRHL1; SERPINB13; ERRFI1;	GO:0045616~regulation of keratinocyte differentiation	6	17	35.2941176470588	0.0461480187732559	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	DRD1; DRD5; GRIA1; SORCS2; PLK2; SHANK2;	GO:0060292~long-term synaptic depression	6	17	35.2941176470588	0.0461480187732559	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	GRM6; ATP2C2; CASR; CXCL12; STC1; TRPV3;	GO:0090280~positive regulation of calcium ion import	6	17	35.2941176470588	0.0461480187732559	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	IGF1; FGF1; ADRA2A; TXN; ADRA2B; ADRA2C; NTF3; IL18; DYNAP;	GO:0032148~activation of protein kinase B activity	9	32	28.125	0.0463680804548593	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	RAMP2; DDAH1; SASH1; IL1A; HSPB1; FGF1; ANXA3; JUP; XBP1; CMA1; CD34; AQP1; CDH5; APLNR; KDR; CHRNA7; GATA4; CCL11; HK2; CX3CL1; TEK; HYAL1; ECM1; PTGIS; ANGPTL4; SMOC2;	GO:0045766~positive regulation of angiogenesis	26	131	19.8473282442748	0.0466558009398752	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	GABRB3; GABRA2; GABRB2; GABRA4; GABRG3; GABRA5; GABRA3; GABRE;	GO:0007214~gamma-aminobutyric acid signaling pathway	8	27	29.6296296296296	0.0474822351564621	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	GFRA3; NFASC; ERBB3; EDNRB; UGT8; NTF3; NTF4; GDNF;	GO:0007422~peripheral nervous system development	8	27	29.6296296296296	0.0474822351564621	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	CIDEA; TRPM2; EDN2; DRD1; ACADL; NMU; ADRB3;	GO:0001659~temperature homeostasis	7	22	31.8181818181818	0.0476390617896102	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	FGF10; CCNB1; PTN; TM4SF4; SOX2; KLK6; TEC;	GO:0042246~tissue regeneration	7	22	31.8181818181818	0.0476390617896102	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	PLAT; CST4; CSTA; CSTB; IDE; SERPINB3; CAMK2N1;	GO:0045861~negative regulation of proteolysis	7	22	31.8181818181818	0.0476390617896102	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	FGF10; SLIT2; GLI2; BMP7; HNF1B; CASR; RASIP1;	GO:0048754~branching morphogenesis of an epithelial tube	7	22	31.8181818181818	0.0476390617896102	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
down	RAMP2; LDHA; PLAT; PENK; MB; CRYAB; CYP1A1; ATP1B1; REG1A; SOD3; BMP2; AHCY; NPPC; CD24; NOS1; ALDH3A1; NOS2; CHRNA7; CXCL12; PSEN2; HK2; HSD11B2; TEK; PLEKHN1; FUNDC1; SCFD1; CITED2; ANGPTL4; EGLN3; ARNT2; NOX4;	GO:0001666~response to hypoxia	31	163	19.0184049079755	0.0490958172891919	0.710879965160601	1	1	0.999999999998363	0.999999999998363	1
